LifeMD Inc (LFMD)

Currency in USD
6.19
-0.14(-2.21%)
Closed·
6.20+0.01(+0.16%)
·
LFMD Scorecard
Full Analysis
Impressive gross profit margins
LFMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.176.48
52 wk Range
3.9915.84
Key Statistics
Prev. Close
6.33
Open
6.35
Day's Range
6.17-6.48
52 wk Range
3.99-15.84
Volume
994.84K
Average Volume (3m)
1.99M
1-Year Change
16.15%
Book Value / Share
-0.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.88
Upside
+108.00%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

LifeMD Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

LifeMD Inc Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeMD Inc SWOT Analysis


Telehealth Triumph
LifeMD's Weight Management Program sees explosive growth, doubling subscribers and driving record patient acquisition in Q1 2024
Diversification Drive
Explore LifeMD's expansion into men's health with new HRT and weight management offerings, positioning for cross-selling opportunities
Financial Forecast
Analysts project 35% revenue growth for FY2024, with adjusted EBITDA margins expected to rise from 8% to 13.5% by FY2025
AI-Powered Scaling
Learn how LifeMD leverages AI to expand provider capacity and improve drug authorization rates, enhancing operational efficiency
Read full SWOT analysis

LifeMD Inc Earnings Call Summary for Q2/2025

  • LifeMD Q2 2025 results: $0.06 loss per share, $62.2M revenue, missing forecasts. Stock dips 4.13% but recovers slightly in after-hours trading.
  • Revenue up 23% YoY, driven by 30% telehealth growth. GAAP net loss improved to $2.9M from $7.7M. Gross margin declined 210 basis points to 88%.
  • 2025 revenue guidance lowered to $250-255M from $268-275M. Telehealth segment projected at $195-200M. Insurance coverage expected to double by year-end.
  • CEO highlights AI integration and improved unit economics with insurance-sponsored patients. High customer acquisition costs for RexMD noted as a challenge.
  • Analysts question RexMD costs, refund policy, and insurance expansion strategies. Company addresses behavioral and women's health program launches.
Last Updated: 05/08/2025, 22:42
Read Full Transcript

Compare LFMD to Peers and Sector

Metrics to compare
LFMD
Peers
Sector
Relationship
P/E Ratio
−32.7x−2.3x−0.6x
PEG Ratio
−0.47−0.010.00
Price/Book
−165.7x1.7x2.6x
Price / LTM Sales
1.2x1.4x3.3x
Upside (Analyst Target)
97.5%35.4%37.4%
Fair Value Upside
Unlock13.6%4.5%Unlock

Analyst Ratings

7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 12.88
(+108.00% Upside)

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
-0.06 / -0.02
Revenue / Forecast
62.20M / 66.29M
EPS Revisions
Last 90 days

LFMD Income Statement

People Also Watch

16.71
OSCR
-0.54%
19.700
ZETA
+0.77%
49.55
BMNR
-7.38%
50.010
ASTS
+6.25%
29.08
CNC
-1.12%

FAQ

What Stock Exchange Does LifeMD Trade On?

LifeMD is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for LifeMD?

The stock symbol for LifeMD is "LFMD."

What Is the LifeMD Market Cap?

As of today, LifeMD market cap is 293.99M.

What Is LifeMD's Earnings Per Share (TTM)?

The LifeMD EPS (TTM) is -0.21.

When Is the Next LifeMD Earnings Date?

LifeMD will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is LFMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has LifeMD Stock Split?

LifeMD has split 1 times.

How Many Employees Does LifeMD Have?

LifeMD has 306 employees.

What is the current trading status of LifeMD (LFMD)?

As of 25 Aug 2025, LifeMD (LFMD) is trading at a price of 6.19, with a previous close of 6.33. The stock has fluctuated within a day range of 6.17 to 6.48, while its 52-week range spans from 3.99 to 15.84.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.